Search Results 1181-1190 of 24164 for Renal
... Renal artery stenting, Renal artery endarterectomy, Aneurysm surgery, Renal artery bypass, Renal artery angioplasty, Celiac artery bypass, Carotid artery ...
ADPKD is a leading cause of end-stage renal disease. Recently, a new medication called Tolvaptan has been approved by the FDA to slow progression of ADPKD ...
... Renal artery stenting, Renal artery endarterectomy, Arteriovenous malformation surgery, Aneurysm surgery, Renal artery bypass, Renal artery angioplasty ...
Rapidly progressive reduction in renal function characterized by. SCr ≥ 2.5 mg/dL; Doubling of SCr within 2 weeks (or for observations of shorter duration ...
This research, supported in part by the Mayo Clinic Center for Regenerative Medicine, provides a foundation on which someday patients with end stage renal ...
The purpose of this study is to assess the serum potassium and cardiac rhythm trends in subjects with end stage renal disease (ESRD) who are on 3 times ...
The purpose of this study is to use urinary exosomes to non-invasively identify (protein biomarkers) various conditions affecting the renal transplant.
Galanis served as the principal investigator in multiple phase 1 and 2 immunovirotherapy trials for ovarian cancer, glioblastoma, renal cell carcinoma ...
... renal disease, Nephrotic syndrome, High blood pressure in children, Renal artery stenosis, Kidney cyst, Acute kidney inury, Hyperoxaluria, Focal segmental ...
Renal artery angioplasty; Renal artery stenting; Suprapubic catheter insertion; Thoracic duct embolization; Transjugular intrahepatic portosystemic shunt ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!